| Code | Description | Claims | Beneficiaries | Total Paid |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
31,324 |
4,139 |
$2.66M |
| 97162 |
|
1,616 |
900 |
$164K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,480 |
1,181 |
$86K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,568 |
1,304 |
$86K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,330 |
3,171 |
$77K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,320 |
3,159 |
$77K |
| 97161 |
|
801 |
412 |
$72K |
| 97163 |
|
449 |
295 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,438 |
5,333 |
$41K |
| 80053 |
Comprehensive metabolic panel |
10,782 |
8,335 |
$40K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,891 |
335 |
$30K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,219 |
1,626 |
$27K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,163 |
2,499 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,160 |
9,357 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,828 |
1,379 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,542 |
1,253 |
$15K |
| 87088 |
|
3,208 |
2,561 |
$13K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
621 |
583 |
$12K |
| 80061 |
Lipid panel |
5,606 |
4,751 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
972 |
816 |
$9K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
962 |
889 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,706 |
2,215 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,740 |
3,123 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
281 |
235 |
$8K |
| 87070 |
|
2,877 |
2,171 |
$7K |
| 82607 |
|
1,454 |
1,168 |
$6K |
| 73630 |
|
551 |
422 |
$6K |
| 86003 |
|
342 |
283 |
$6K |
| 84439 |
|
2,184 |
1,755 |
$6K |
| 86780 |
|
1,061 |
830 |
$5K |
| 87186 |
|
1,059 |
788 |
$5K |
| 86038 |
|
695 |
471 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,288 |
1,043 |
$4K |
| 86225 |
|
799 |
538 |
$3K |
| 82746 |
|
848 |
649 |
$3K |
| 80055 |
|
318 |
224 |
$3K |
| 72110 |
|
181 |
141 |
$3K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
733 |
514 |
$3K |
| 73610 |
|
167 |
130 |
$3K |
| 82570 |
|
1,622 |
1,388 |
$3K |
| 85610 |
|
1,585 |
837 |
$3K |
| 87077 |
|
1,535 |
1,119 |
$3K |
| 81001 |
|
2,407 |
1,903 |
$2K |
| 83970 |
|
168 |
137 |
$2K |
| 83550 |
|
792 |
631 |
$2K |
| 82728 |
|
1,005 |
784 |
$2K |
| 87340 |
|
567 |
467 |
$2K |
| 80074 |
|
205 |
181 |
$2K |
| 74018 |
|
229 |
186 |
$2K |
| 87081 |
|
865 |
716 |
$2K |
| 73130 |
|
233 |
155 |
$2K |
| 85027 |
|
938 |
731 |
$2K |
| 82043 |
|
1,439 |
1,253 |
$2K |
| 80076 |
|
556 |
462 |
$2K |
| 80306 |
|
354 |
301 |
$2K |
| 73564 |
|
142 |
103 |
$2K |
| 83655 |
|
179 |
160 |
$2K |
| 86140 |
|
901 |
579 |
$2K |
| 73030 |
|
118 |
91 |
$1K |
| 86850 |
|
864 |
724 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
191 |
171 |
$1K |
| 86901 |
|
1,013 |
822 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
109 |
81 |
$1K |
| 84481 |
|
332 |
258 |
$1K |
| 86787 |
|
199 |
151 |
$1K |
| 83516 |
|
229 |
180 |
$1K |
| 80069 |
|
347 |
272 |
$1K |
| 85652 |
|
1,277 |
852 |
$1K |
| 72100 |
|
93 |
83 |
$1K |
| 83735 |
|
694 |
422 |
$1K |
| 86762 |
|
557 |
471 |
$1K |
| 82950 |
|
738 |
646 |
$1K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
325 |
306 |
$1K |
| 83540 |
|
529 |
437 |
$1K |
| 84702 |
|
267 |
192 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
53 |
51 |
$1K |
| 86900 |
|
881 |
735 |
$907.59 |
| 80164 |
|
291 |
255 |
$883.93 |
| 86430 |
|
330 |
201 |
$777.51 |
| 72114 |
|
27 |
27 |
$739.55 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
98 |
54 |
$725.77 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
115 |
83 |
$717.87 |
| 87493 |
|
34 |
26 |
$715.77 |
| 72050 |
|
35 |
27 |
$598.82 |
| 82951 |
|
102 |
85 |
$541.23 |
| 86747 |
|
18 |
15 |
$495.84 |
| 84403 |
|
26 |
24 |
$456.12 |
| 86706 |
|
49 |
37 |
$435.85 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
67 |
66 |
$422.88 |
| 82784 |
|
104 |
69 |
$396.40 |
| 86618 |
|
37 |
28 |
$338.12 |
| 83525 |
|
38 |
36 |
$284.47 |
| 84550 |
|
184 |
137 |
$280.49 |
| 97166 |
|
25 |
13 |
$278.06 |
| 85730 |
|
121 |
86 |
$251.24 |
| 82247 |
|
121 |
82 |
$248.45 |
| 87045 |
|
54 |
39 |
$241.24 |
| 86704 |
|
17 |
12 |
$235.24 |
| 81003 |
|
298 |
241 |
$232.56 |
| 87280 |
|
34 |
21 |
$213.92 |
| 83001 |
|
24 |
13 |
$206.57 |
| 82952 |
|
89 |
82 |
$185.16 |
| 87210 |
|
109 |
74 |
$174.89 |
| 84146 |
|
34 |
25 |
$158.88 |
| 86200 |
|
35 |
26 |
$152.91 |
| 72072 |
|
15 |
12 |
$124.03 |
| 82248 |
|
77 |
64 |
$93.14 |
| 83002 |
|
23 |
12 |
$83.33 |
| 84100 |
|
92 |
53 |
$77.54 |
| 83690 |
|
45 |
44 |
$66.03 |
| 85045 |
|
64 |
42 |
$60.96 |
| 84156 |
|
58 |
42 |
$43.68 |
| 84480 |
|
14 |
13 |
$36.39 |
| 83615 |
|
30 |
24 |
$34.80 |
| 87106 |
|
38 |
26 |
$32.86 |
| 88142 |
|
17 |
17 |
$29.56 |